SpectrumX CEO Damien Hancox joins Proactive Katie Pilbeam in the London studio to talk about the SPC-069 treatment and what the roadmap looks like for releasing to the market.
Home » SpectrumX Holdings » SpectrumX CEO Damien Hancox joins Proactive Katie Pilbeam in the London studio to talk about the SPC-069 treatment